LauraHBachmannMDMPH
Infectious Disease • Atlanta, GAHIV/AIDS Medicine, STD Medicine
Chief Medical Officer, Division of STD Prevention, Centers for Disease Control and Prevention
Dr. Bachmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Clifton Rd NE
Atlanta, GA 30333Phone+1 404-718-5053
Education & Training
University of Alabama Medical CenterFellowship, Infectious Disease, 1997 - 2000
University of Alabama at Birmingham School of Public HealthMPH, Epidemiology, 1997 - 1999- University of Alabama Medical CenterResidency, Internal Medicine, 1994 - 1997
University of North Carolina at Chapel Hill School of MedicineClass of 1994
Certifications & Licensure
GA State Medical License 2018 - 2026
NC State Medical License 2008 - 2025
AL State Medical License 1995 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013
Clinical Trials
- Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections Start of enrollment: 2003 Jun 01
- Risk Assessment of Long-Haul Truck Drivers Start of enrollment: 2005 Sep 01
Publications & Presentations
PubMed
- 7 citationsWHO global research priorities for sexually transmitted infections.Sami L Gottlieb, Erica Spielman, Laith Abu-Raddad, Adeniyi Kolade Aderoba, Laura H Bachmann
The Lancet. Global Health. 2024-09-01 - 1 citationsVaccine value profile for herpes simplex virus.Christine Johnston, Suzanne Scheele, Laura Bachmann, Marie-Claude Boily, Nathorn Chaiyakunapruk
Vaccine. 2024-07-25 - FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.Hiwot Hiruy, Shukal Bala, James M Byrne, Kerian Grande Roche, Seong H Jang
Clinical Infectious Diseases. 2024-07-24
Press Mentions
Addressing the Rise of Syphilis in the U.S.September 7th, 2024- US Is Investigating First Two Cases of Super Strength Gonorrhea StrainFebruary 1st, 2023
- Two Cases of New Drug-Resistant Gonorrhea Strain Reported in MassachusettsJanuary 23rd, 2023
- Join now to see all
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
